Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer

NCT01324141 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

NIH

Sponsor class

Stopped Slow, insufficient accrual and failure to meet endpoints.

Conditions

Anal Cancer

Interventions

DRUG: Tempol
DRUG: 5-Fluorouracil
DRUG: Mitomycin-C
PROCEDURE: Radiation Therapy

Sponsor

National Cancer Institute (NCI)